After the yield of " Yikes " CoreWeave bonds touched 15%, the stock price tumbled 13%
Coinpaper
1h ago
Ai Focus
On October 14, the stock price of CoreWeave fell by about 13%, and the bond yield approached 15%, sparking concerns in the market about its financing risks. Musk only responded with " Yikes " to this. Although the company has an order backlog of approximately $104.2 billion, high interest expenses and future capital expenditures continue to draw investors' attention.
Helpful
No.Help

Key Points

  • CoreWeave Stock Price Falls 13%, Credit Worsenings Intensify
  • Elon Musk reacts after bond yields hit 15%
  • CoreWeave A contrast between $104.2 billion in backlogged orders and financing risks

On October 14th, the stock price of CoreWeave, an infrastructure company supported by Nvidia (NASDAQ: CRWV), fell by about 13%. The reason was that its bond yield approached 15%, which triggered a brief response from Elon Musk and once again raised concerns in the market regarding the massive debt financing that supports the boom in artificial intelligence.

CRWV's stock price fell to around $67.52, closing at its lowest level since July 29th, with the cumulative decline since October expanding to about 20%. While the demand for advanced computing power continues to exist, this round of selling also coincides with the widespread concerns about rising borrowing costs faced by AI infrastructure companies.

The risk controversy escalated further after risk investor Chamath Palihapitiya shared a chart. The chart showed that the yield on CoreWeave bonds reached 15%, and he warned that there might be a private credit bubble. Musk simply replied with one word: “Yikes.”

Why did the stock price of CoreWeave fall when bond yields reached 15%?

The core concern of the market lies in the increasingly expensive debt of CoreWeave, as well as the company's ability to finance the continued expansion of its AI infrastructure.

According to reports from Barron, the yield on CoreWeave's senior unsecured notes, which mature in 2032 with a coupon rate of 9.625%, has risen from around 13.42% at the beginning of October to 15.06%.

At the same time, the market price of these bonds fell from approximately $85 per $100 face value to $79.50, indicating that investors are demanding higher returns in order to be willing to hold CoreWeave debt.

This is very important because it refers to the yield of a particular bond in the secondary market, and not to the interest rate applicable to all loans under CoreWeave. However, such a high yield may still indicate that market concerns about credit risk are on the rise, which also means that the company's future financing costs could be higher.

As investors question whether massive investments in infrastructure will yield sufficient returns, the stock price of CoreWeave is also under pressure from broader debates regarding AI financing.

CoreWeave has a backlog of orders worth $104.2 billion, but debt costs are also on the rise

This sharp decline stands in stark contrast to the huge future contract revenues of CoreWeave.

In its second-quarter financial report, the company disclosed that as of June 30, it had an order backlog of approximately $104.2 billion, a 246% increase compared to the same period last year.

Quarterly revenue more than doubled year-on-year, reaching $2.58 billion, reflecting the strong demand from AI developers, hyperscale cloud service providers, and enterprise customers.

However, CoreWeave also recorded net interest expenses of approximately $640 million and a net loss of $626 million for that quarter.

The company expects its capital expenditures to reach $35 billion to $39 billion in 2026, highlighting its funding needs for purchasing Nvidia GPU, expanding data centers, and ensuring power and cooling infrastructure.

Order backlogs can provide visibility for future business, but they do not equate to cash that can be used to repay debts immediately. Contracts still need to be fulfilled, and infrastructure investments typically require financing in advance before the customer payments have been fully recovered.

These challenges became apparent when CoreWeave announced the issuance of convertible bonds in September to support its expansion.

As concerns about AI debt rise, CoreWeave turns to insurance capital

Another development has added a new dimension to the company's financing challenges.

According to the Financial Times, CoreWeave is attempting to attract life insurance funds through a financing structure supported by GPU in order to strive for an investment-grade credit rating.

Reports indicate that as of June, the company's total debt and leasing obligations amounted to approximately $52 billion, while it has already secured over $35 billion in financing for 2026.

Obtaining capital from insurance companies may provide a longer-term source of funding for the AI infrastructure project and is expected to reduce reliance on more expensive financing arrangements.

Tip
$0
Like
0
Save
0
Views 22
HKWDB reminds readers to view blockchain rationally, stay aware of risks, and beware of virtual token issuance and speculation. All content on this site represents market information or related viewpoints only and does not constitute any form of investment advice. If you find sensitive content, please click“Report”,and we will handle it promptly。
Submit
Comment 0
Hot
Latest
No comments yet. Be the first!
Related
Encrypted wallet extended to include DeFi central trading and earnings functions, now integrated within the application
MetaMask, Phantom, and Jupiter are integrating transaction, lending, payment, and earnings functions into their wallet applications. The article outlines the different approaches of each company regarding transaction fees, routing, gasless transactions, stablecoin earnings, as well as US regulations and taxation.
crypto.news
·2026-10-15 00:17:18
12
Prismm Helps banks keep inherited funds within the system
Prismm is a startup founded in 2020 that helps banks more smoothly transfer assets to heirs after the death of an account holder, thereby reducing the outflow of funds to other institutions. The company presented its mission and products on the TechCrunch Disrupt 2026 stage.
TechCrunch
·2026-10-15 00:17:13
16
TruGolf Links hires Polymath to tokenize equity ledgers
TruGolf Holdings announces that its franchise subsidiary TruGolf Links has signed an inter-company agreement with its tokenization subsidiary Polymath Research. Professional services will be provided by Polymath, and the capital balance of TruGolf Links will be migrated to the tokenized ledger on Polymesh. This arrangement was reached six days after TruGolf completed the acquisition of Polymath on October 8th, and it represents the first Polymath cooperation project signed following the merger.
PR Newswire
·2026-10-14 23:55:35
16
With the rise of personal AI agents, DeepLumen helps merchants transform AI into new sales channels.
DeepLumen indicates that its flagship product, Agentic Page, has been installed by nearly 2,000 Shopify merchants, which is used to enable the AI system to obtain the latest business information and track orders brought in by traffic from AI. The company states that as the newly launched personal AI agency Muse expands to Shopify directories as well as payment connections such as Shop Pay and PayPal, consumers are increasingly entrusting their shopping tasks to AI. Merchants, in turn, need to transform product discovery driven by AI into attributable sales.
PR Newswire
·2026-10-14 23:55:33
16
Apple's Ge Yue: It is estimated that over 1 billion people worldwide are affected by sleep apnea.
Ge Yue, the Managing Director of Apple's Greater China region, stated that it is estimated that over 1 billion people worldwide are affected by sleep apnea, but most patients have not yet been diagnosed. She mentioned that Apple has launched the "Sleep Apnea Indicators" feature, which can help users detect potential signs of moderate to severe sleep apnea. Previously, reports from IT Home indicated that Apple had already introduced the "Sleep Apnea Notification" feature in mainland China, which had previously been approved by the National Medical Products Administration and entered the market as a Class II medical device.
The Block
·2026-10-14 23:55:31
13
View More